Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
322.7 USD | -1.30% | +0.25% | +19.22% |
May. 14 | DBS Bank Initiates HCA Healthcare at Buy Rating With $370 Price Target | MT |
May. 13 | Hca Healthcare Insider Sold Shares Worth $516,450, According to a Recent SEC Filing | MT |
Evolution of the average Target Price on HCA Healthcare, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering HCA Healthcare, Inc.
DBS Bank | |
TD Cowen | |
Leerink Partners | |
UBS | |
RBC Capital Markets | |
Oppenheimer | |
Barclays | |
Mizuho Securities | |
Truist Securities | |
Deutsche Bank Securities | |
Wells Fargo Securities | |
Raymond James | |
Bernstein | |
Goldman Sachs | |
Argus | |
JPMorgan Chase | |
Stephens Inc. | |
Baptista Research | |
Credit Suisse | |
Jefferies & Co. | |
Citigroup | |
BofA Securities | |
Loop Capital | |
Cantor Fitzgerald | |
Cowen | |
SVB Securities LLC | |
BMO Capital | |
SVB Leerink | |
Seaport Global Securities |
EPS Revisions
- Stock Market
- Equities
- HCA Stock
- Consensus HCA Healthcare, Inc.